A Review on Role of Nanoparticles in Anticancer Drugs

Kushwah Pratibha; Mandloi Rampal; Pillai Sujit; Birla Nikhlesh; Sen Aayush

doi:10.5958/0975-4385.2020.00028.X

Research Journal of Pharmacognosy and Phytochemistry

ISSN

0975-4385 (Online)
0975-2331 (Print)

Submit Article

A Review on Role of Nanoparticles in Anticancer Drugs

Author(s): Kushwah Pratibha, Mandloi Rampal, Pillai Sujit, Birla Nikhlesh, Sen Aayush

Email(s): Email ID Not Available

DOI: 10.5958/0975-4385.2020.00028.X

Address: Kushwah Pratibha, Mandloi Rampal, Pillai Sujit, Birla Nikhlesh, Sen Aayush
GRY Institute of Pharmacy, Borawan, Khargone (M.P.), India, Bhopal.
*Corresponding Author

Published In: Volume - 12, Issue - 3, Year - 2020

View HTML

View PDF

ABSTRACT:
Recent advancement in nanotechnology provide effective and safe drug delivery systems for successful delivery of anticancer agents via nanoparticles.Anticancer therapies mostly depends on the ability of the drug to reach their cellular and subcellular target sites, while minimizing accumulation and side effects at non specific sites.Nanosized particles have novel structural and physical properties that attracting great interests from pharmaceuticals for targeted delivery of anticancer drugs. Nanocarries are able to reduce cytotoxic effects of the active anticancer drugs by increasing cancer cells targeting in comparison to conventional formulations. This review focuses on classification, method of preparation, characterization, application of nanoparticles in cancer treatments.

Keywords:

Cite this article:
Kushwah Pratibha, Mandloi Rampal, Pillai Sujit, Birla Nikhlesh, Sen Aayush. A Review on Role of Nanoparticles in Anticancer Drugs. Res. J. Pharmacognosy and Phytochem. 2020; 12(3):168-173. doi: 10.5958/0975-4385.2020.00028.X

Cite(Electronic):
Kushwah Pratibha, Mandloi Rampal, Pillai Sujit, Birla Nikhlesh, Sen Aayush. A Review on Role of Nanoparticles in Anticancer Drugs. Res. J. Pharmacognosy and Phytochem. 2020; 12(3):168-173. doi: 10.5958/0975-4385.2020.00028.X Available on: https://rjpponline.org/AbstractView.aspx?PID=2020-12-3-8

REFERENCES:

1. D.peer, J. M. Karp, S. Hong, O. C. Farokhzad "Nanocarriers as an emerging platform for cancer therapy" Nuture Nanotechnology, (2007), vol.2, 715- 760.

2. Jain N.K. “Introduction to Novel Drug delivery system” First edition (2010) Vallabh-prakashan, page no. 134-153.

3. Patel J Dimendra, Mistri A Pratik, prajapti Jatin “Treatment of cancer by using Nanopartticles as a drug Delivery” Internationational Journal of drug Development and research, (2012), 4(1): 14-27

4. Pillai Gopalkirshana, “Nanomedicines for cancer therapy: an update of FDA Approved and those under various stages of Development” SOJ Pharmacy And pharmaceutical sciences, (2014), 1041-1047.

5. Syed A.A, Rizvi and Ayman M. Saleh. Application of nanopartical systems in drug delivery technology. Saudi pharmaceutical JournaL: SPO (2016); 6(6):1063-1084.

6. Gour A. Mindha A, Bhatiya AL "Nanotechnology in medical sciences" Asian journal of pharmaceutics, (2008), 80-85.

7. Konwar Ranjit, Ahmed Abdul Bahurenge "Nanoparticle: An overview of preparation, characterization, and Application” International Research journal of pharmacy, (2013), 47-57.

8. Mohanraj Vj, Chen Y "Nanoparticle a review" Topical journal of pharmaceutical Research, (2006), 561-573.

9. Heera P and Shanmugam S. “Nanoparticle Characterization and Application: An review” International journal of current Microbiology and Applied sciences, (2015), vol. 4, 379-386.

10. Fisuri Funmilola A, Schatzlein Andreas G “Nanomedicines in the treatment of brain tumors” Nanomedicines, (2018), 579-583.

11. Pal Savan Lal, Jana Utpal, Manna P. K., Mohanta G. P., manavalan R “Nanoparticle: An overview of preparation and characterization” Journal of Applied Pharmaceutical Science. (2011), 228-234.

12. Biswas Amit kumar, islam Md Reazul, Choudary Zahid Sadek, MastafaAslif and Kadir Mahammad Fhim “Nanotechnology based approaches in cancer therapeutics” Advances in Natural Sciences: and Nenotechnology, (2014), Vol.5, 4-27.

13. Bhagwat R.R, Vaidhya I.s. Novel Drug delivery systems: An overview, International journal Pharmaceutical Sciences and research. (2013), vol.4, 970-982.

14. Tyagi Swati, Panday vinaykumar. “Nanoparticle: An overview of preparation” Journal of pharmaceutics and Nanotechnology, 2016, vol. 7, 2347-7857.

15. Labal Muhammade, Elassari Abdelhamid. “Double Emulsion solvent Evaporation Techniques used for drug encapsulation” International Journal of Pharmaceutics. (2015), Volume 496, issue 2, page no. 173-190.

16. Allemann E, Doelkar E, Fessih. “A mechanistic study of the formation of polymer nanoparticles by the Emulsification-Diffusion Technique” Colliod and Polumer science. (1997), volume 275, page no.640-647.

17. F. Mohamed, AntonNicolas, jwallyn Justine "An overview of active and passive targeting to improve the nanocarriers efficiency to tumor sites" journal of pharmacy and pharmacology, (2019), vol. 17. Page no.1185-1193.

18. Bushr E, Senbftleben N. Characterization of nanoparticles by scanning electron microscopy in transmission mode. Measurement science and Technology. (2009), Volume 20. Page no.93-95.

19. Stetefeld Jorg, A sean, Patel TrusharR “Dynamic lighat scattering: A practicle guide abd application in Biomedical science” Biophysical Reviews, (2016), 8(4), 409-427.

20. Tekchadani pawan, paliwal snivani Rai, kurmi Balak Das. “Nanomedicine to deal with cancer cell Biology in multidrug Resistance” (2017), volume 17, issue 8, page no.1-3.

21. Hare Jennifer I, Barry simon T. “Challenges and strategies in Anticancer Nanomedicines development: An industry perspective” Advanced Drug Delivery Reviews, (2017), volume 108, page no. 25-38.

22. Rajendra Awasthi, Dua Kmal, Rathbone micheal phlip. “Nanoparticles in cancer treatment opportunities and obstacles” Current drug target, (2018), volume 19, issue 4, page no.1696-1703.

23. Bregil carlos, and Carlucci Adriana “Nanomedicines in cancer therapy” Journal of molecular pharmaceuticals and organic process Research, (2013), vol.1, 101.

24. Swain Suryakanta, Sahu Praful kumar, Beg Sarwar, BabuSitty Manohar “Nanoparticle for cancer targeting: Current and future Directions” Current Drug delivery System, (2016), Vol.13, issue 8, Page no. 1290-1302.

25. Conuor Allegra, RauthAndreud M, Manias janet, Shuhendler Adam J.A “novel Doxorubicin-MitomycinC coencapsulated Nanoparticle formulation exhibits” anticancer synergy in multidrug resistant human breast cancer cell, (2010), 119:255.

26. Hare Jennifer I, Barry simon T. “Challenges and strategies in Anticancer Nanomedicines development: An industry perspective” Advanced Drug Delivery Reviews, (2017), volume 108, page no. 25-38.